Titan Biotech Limited announced unaudited consolidated and standalone earnings results for third quarter and nine months ended Dec. 31, 2016. For the quarter, the company reported standalone net sales/income from operations of INR 122.825 million, profit from operations before other income, finance costs & exceptional items of INR 15.632 million, profit before tax of INR 9.224 million, net profit of INR 3.339 million or INR 0.43 per basic and diluted share compared to the net sales/income from operations of INR 115.107 million, profit from operations before other income, finance costs & exceptional items of INR 7.290 million, profit before tax of INR 6.816 million, net profit of INR 4.268 million or INR 0.55 per basic and diluted share for the same quarter a year ago. For the year to date, the company reported standalone net sales/income from operations of INR 374.459 million, profit from operations before other income, finance costs & exceptional items of INR 33.130 million, profit before tax of INR 23.339 million, net profit of INR 13.697 million or INR 1.34 per basic and diluted share compared to the net sales/income from operations of INR 331.801 million, profit from operations before other income, finance costs & exceptional items of INR 24.008 million, profit before tax of INR 19.563 million, net profit of INR 12.271 million or INR 1.59 per basic and diluted share for the same period a year ago. For the quarter, the company reported consolidated net sales/income from operations of INR 123.530 million, profit from operations before other income, finance costs & exceptional items of INR 15.468 million, profit before tax of INR 8.778 million, net profit of INR 2.866 million or INR 0.37 per basic and diluted share compared to the net sales/income from operations of INR 133.275 million, profit from operations before other income, finance costs & exceptional items of INR 8.013 million, profit before tax of INR 6.989 million, net profit of INR 6.553 million or INR 0.72 per basic and diluted share for the same quarter a year ago. For the year to date, the company reported consolidated net sales/income from operations of INR 376.815 million, profit from operations before other income, finance costs & exceptional items of INR 32.532 million, profit before tax of INR 22.724 million, net profit of INR 13.001 million or INR 1.31 per basic and diluted share compared to the net sales/income from operations of INR 457.705 million, profit from operations before other income, finance costs & exceptional items of INR 30.805 million, profit before tax of INR 26.512 million, net profit of INR 17.662 million or INR 2.28 per basic and diluted share for the same period a year ago.